In 2023, Canada's share of scientific publications among the world's top 10% cited works in immunology and allergy was noted. Looking ahead, the forecast from 2024 to 2028 indicates a stable trend, with a marginal increase in share by 2028.
Year-on-year variation highlights consistency, with a steady growth rate predicted over the next years, remaining nearly constant at a CAGR that reflects gradual improvement. This suggests Canada’s persistent prominence and competitive edge in the field.
Trends to watch for include technological advancements in immunological research, strategic collaborations, and increased funding, which could further boost Canada’s academic influence in this specialized domain.
